ASHLEY STINES: Open Payments
NPI 1497373328 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$14,071 in 78 payments from 7 companies in 2025. Trend: 2023 $4,182 · 2024 $9,580 · 2025 $14,071
Speaker / faculty: $7,800Travel & lodging: $4,263Food & beverage: $2,008
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 47 | $13,351 |
| ViiV Healthcare Company | 24 | $555 |
| Merck Sharp & Dohme LLC | 3 | $81 |
| SHIELD THERAPEUTICS INC | 1 | $34 |
| Novo Nordisk Inc | 1 | $18 |
| Corcept Therapeutics | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Biktarvy, DOVATO, CABENUVA, PIFELTRO, ACCRUFER, Wegovy, Korlym, Cologuard Collection Kit.
Industry payments across AL — which companies pay providers there.
